Cowen And Company, LLC Amicus Therapeutics, Inc. Put Options Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 09, 2023	BUY	$9.89 - $12.7 $49,450 - $63,500	5,000 New	5,000 $61,000
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $450,110 - $609,760	-51,500 Reduced 57.87%	37,500 $24,000
Q2 2021 Aug 13, 2021	BUY	$8.71 - $10.72 $122,811 - $151,152	14,100 Added 18.83%	89,000 $64,000
Q1 2021 May 04, 2021	BUY	$9.2 - $23.86 $689,080 - $1.79 Million	74,900 New	74,900 $99,000
Q3 2020 Nov 03, 2020	SELL	$12.89 - $15.89 $128,900 - $158,900	-10,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $88,600 - $156,900	10,000 New	10,000 $11,000

312

311M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.56B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.